A mouse model to identify cooperating signaling pathways in cancer

Article metrics

Abstract

We here establish a mouse cancer model called Multi-Hit that allows for the evaluation of oncogene cooperativities in tumor development. The model is based on the stochastic expression of oncogene combinations ('hits') that are mediated by Cre in a given tissue. Cells with cooperating hits are positively selected and give rise to tumors. We used this approach to evaluate the requirement of Ras downstream effector pathways in tumorigenesis.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: The RasE Multi-Hit mouse model.
Figure 2: Lung adenocarcinomas in RasEAdCre mice.
Figure 3: Histopathological evaluation of lung tumors.

References

  1. 1

    Hanahan, D. & Weinberg, R.A. Cell 144, 646–674 (2011).

  2. 2

    Downward, J. Nat. Rev. Cancer 3, 11–22 (2003).

  3. 3

    Malumbres, M. & Barbacid, M. Nat. Rev. Cancer 3, 459–465 (2003).

  4. 4

    Giehl, K. Biol. Chem. 386, 193–205 (2005).

  5. 5

    Repasky, G.A., Chenette, E.J. & Der, C.J. Trends Cell Biol. 14, 639–647 (2004).

  6. 6

    Khosravi-Far, R. et al. Mol. Cell. Biol. 16, 3923–3933 (1996).

  7. 7

    Blaas, L. et al. Biotechniques 43, 659–660, 662, 664 (2007).

  8. 8

    Zhang, Y., Buchholz, F., Muyrers, J.P. & Stewart, A.F. Nat. Genet. 20, 123–128 (1998).

  9. 9

    Rangarajan, A., Hong, S.J., Gifford, A. & Weinberg, R.A. Cancer Cell 6, 171–183 (2004).

  10. 10

    DuPage, M., Dooley, A.L. & Jacks, T. Nat. Protoc. 4, 1064–1072 (2009).

  11. 11

    McCormick, F. J. Surg. Oncol. 103, 464–467 (2011).

  12. 12

    Gupta, S. et al. Cell 129, 957–968 (2007).

  13. 13

    Doehn, U. et al. Mol. Cell 35, 511–522 (2009).

  14. 14

    Mishra, P.J. et al. Oncogene 29, 2449–2456 (2010).

  15. 15

    Drosten, M. et al. EMBO J. 29, 1091–1104 (2010).

  16. 16

    Joneson, T., White, M.A., Wigler, M.H. & Bar-Sagi, D. Science 271, 810–812 (1996).

  17. 17

    White, M.A. et al. Cell 80, 533–541 (1995).

  18. 18

    Chappell, S.A., Edelman, G.M. & Mauro, V.P. Proc. Natl. Acad. Sci. USA 101, 9590–9594 (2004).

  19. 19

    Yusufzai, T.M. & Felsenfeld, G. Proc. Natl. Acad. Sci. USA 101, 8620–8624 (2004).

  20. 20

    Hochedlinger, K., Yamada, Y., Beard, C. & Jaenisch, R. Cell 121, 465–477 (2005).

  21. 21

    Hameyer, D. et al. Physiol. Genomics 31, 32–41 (2007).

  22. 22

    Suzuki, A. et al. Immunity 14, 523–534 (2001).

  23. 23

    Vasioukhin, V., Degenstein, L., Wise, B. & Fuchs, E. Proc. Natl. Acad. Sci. USA 96, 8551–8556 (1999).

Download references

Acknowledgements

We thank J. Downward (London Research Institute) for Ras effector mutants, A. Berns (Netherlands Cancer Institute) for Rosa26CreERT2 mice and G. Felsenfeld (National Institute of Diabetes and Digestive and Kidney Diseases, USA) for chicken 2xHS4 insulator sequences. We thank M. Sibilia and E.F. Wagner for critical reading of the manuscript and M. Mair and D. Khan for technical assistance. This work was supported by the Ludwig Boltzmann Gesellschaft (LBG), the Austrian Science Fund (FWF) grant SFB F28 to M. Müller, R.M. and R.E., the FWF Doktoratskolleg-plus grant 'Inflammation and Immunity' to M. Müller and R.E., the CCC Vienna Research grant to E.C. and R.E. and the Austrian Federal Ministry of Science and Research GENAU grant 'Austromouse' to M. Müller, T.R., J.M.P., E.C. and R.E. J.M.P. is supported by the Institute of Molecular Biotechnology (IMBA) and an advanced European Research Council (ERC) grant.

Author information

M. Musteanu performed the study and interpreted data. L.B., R.Z., J.S., T.H., B.G. and D.S. provided major technical support. H.-P.K., M. Müller, T.K., T.R., R.M., L.K., D.S. and J.M.P. provided technical support. H.P. provided histopathological support and interpreted data. E.C. designed and supervised the study. R.E. designed and supervised the study, interpreted data and wrote the manuscript.

Correspondence to Robert Eferl.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–9. (PDF 2749 kb)

Rights and permissions

Reprints and Permissions

About this article

Further reading